Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic

Summary

This phase II trial studies how well molecularly targeted therapy works in treating patients with melanoma that has spread to other parts of the body. Patients must have received or do not qualify for prior immunotherapy. Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific types of cancer cells with less harm to normal cells. Molecularly targeted therapy works by treating patients with substances that kill cancer cells by targeting key molecules involved in cancer cell growth.

Timeline

Start

2014-05

Primary completion

2018-12

Completion

2018-12

Drugs

Indications